|
Market Closed -
NSE India S.E.
09:05:07 11/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 1,366.00 INR | -0.53% |
|
-1.37% | -9.61% |
| 04/09 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 25/08 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,509.08 | +10.47% | 36 | |||||||
| 2,167.21 | +17.78% | 33 | |||||||
| 14,433.33 | +27.33% | 12 | |||||||
| 1,195.78 | +6.85% | 30 | |||||||
| 257.83 | -0.83% | 6 | |||||||
| 13,214.57 | +5.46% | 7 | |||||||
| - | 2,508.33 | +8.12% | 12 | ||||||
| 2,497.73 | +3.25% | 11 | |||||||
| - | - | - | - | - | |||||
| 3,796.46 | +7.44% | 13 | |||||||
| 172.67 | +9.98% | 3 | |||||||
| 15.11 | +59.69% | 4 | |||||||
| - | - | 133.12 | -1.1% | 2 | |||||
| - | - | - | - | - | |||||
| - | 154.68 | +12.74% | 4 | ||||||
| - | - | 14.6 | +8.07% | 1 | |||||
| - | 2,765 | +0.37% | 2 | ||||||
| Average | 2,989.03 | +11.71% | 12 | ||||||
| Weighted average by Cap. | 5,270.7 | +15.72% | 19 |
- Stock Market
- Stocks
- CIPLA Stock
- Sector Cipla Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















